We are live on
!
Find out more
WF
Welch & Forbes Portfolio holdings
AUM
$8.23B
1-Year Est. Return
17.62%
This Fund
S&P 500
This Quarter
Est. Return
-1.2%
1 Year Est. Return
+17.62%
3 Year Est. Return
+73.71%
5 Year Est. Return
+105.59%
10 Year Est. Return
+384.92%
AUM
$3.88B
AUM Growth
+$134M
(+3.6%)
Cap. Flow
+$219M
Cap. Flow
% of AUM
5.65%
Top 10 Holdings %
Top 10 Hldgs %
22.53%
Holding
368
New
30
Increased
108
Reduced
154
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$51M |
| 2 |
Chubb
CB
|
+$44M |
| 3 |
Abbott
ABT
|
+$37.6M |
| 4 |
Aflac
AFL
|
+$31M |
| 5 |
AT&T
T
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EACQ
Easterly Acquisition Corp
EACQ
|
+$10M |
| 2 |
CVS Health
CVS
|
+$6.32M |
| 3 |
SRCL
Stericycle Inc
SRCL
|
+$4.84M |
| 4 |
WisdomTree Europe Hedged Equity Fund
HEDJ
|
+$4.74M |
| 5 |
ExxonMobil
XOM
|
+$4.59M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.2% |
| 2 | Technology | 17.48% |
| 3 | Financials | 12.88% |
| 4 | Industrials | 9.97% |
| 5 | Consumer Discretionary | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Vanguard FTSE All-World ex-US ETF
VEU
$66.8B
| $5.9M | 0.15% |
108,541
+55
| +0.1% | +$3.06K |
|
127
Sherwin-Williams
SHW
$83.7B
| $5.84M | 0.15% |
44,679
-894
| -2% | -$122K |
|
128
Kimberly-Clark
KMB
$36.6B
| $5.76M | 0.15% |
52,349
-1,002
| -2% | -$114K |
|
129
BP
BP
$114B
| $5.55M | 0.14% |
147,467
-3,913
| -3% | -$147K |
|
130
iShares Russell 2000 ETF
IWM
$80.2B
| $5.55M | 0.14% |
36,574
+1,217
| +3% | +$188K |
|
131
CF Industries
CF
$19.3B
| $4.89M | 0.13% |
129,530
-7,418
| -5% | -$302K |
|
132
General Mills
GIS
$19.4B
| $4.65M | 0.12% |
103,140
-4,776
| -4% | -$259K |
|
133
WisdomTree Japan Hedged Equity Fund
DXJ
$7.13B
| $4.64M | 0.12% |
82,813
+150
| +0.2% | +$8.73K |
|
134
Johnson Controls International
JCI
$87.8B
| $4.5M | 0.12% |
+127,687
| New | +$4.85M |
|
|
APC
135
DELISTED
Anadarko Petroleum
APC
| $4.48M | 0.12% |
74,209
-150
| -0.2% | -$8.79K |
|
136
Union Pacific
UNP
$172B
| $4.23M | 0.11% |
31,485
+2,297
| +8% | +$309K |
|
|
TWX
137
DELISTED
Time Warner Inc
TWX
| $4.15M | 0.11% |
43,881
-855
| -2% | -$80.6K |
|
|
AGN
138
DELISTED
Allergan plc
AGN
| $4.03M | 0.1% |
23,968
-358
| -1% | -$60K |
|
139
Charter Communications
CHTR
$16.9B
| $3.94M | 0.1% |
12,670
-542
| -4% | -$191K |
|
140
Zimmer Biomet
ZBH
$18.4B
| $3.77M | 0.1% |
35,560
-2,025
| -5% | -$235K |
|
141
Tractor Supply
TSCO
$15.8B
| $3.74M | 0.1% |
296,570
-14,425
| -5% | -$201K |
|
142
MetLife
MET
$62.5B
| $3.67M | 0.09% |
79,860
-11,981
| -13% | -$581K |
|
143
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.3B
| $3.47M | 0.09% |
29,085
+21,720
| +295% | +$2.62M |
|
144
Texas Instruments
TXN
$255B
| $3.4M | 0.09% |
32,706
+1,511
| +5% | +$164K |
|
145
Boeing
BA
$175B
| $3.37M | 0.09% |
10,274
-125
| -1% | -$42.2K |
|
146
iShares MSCI Emerging Markets ETF
EEM
$28.6B
| $3.32M | 0.09% |
68,682
+2,750
| +4% | +$135K |
|
147
Progressive
PGR
$124B
| $3.3M | 0.09% |
54,119
+322
| +0.6% | +$18.4K |
|
148
Northrop Grumman
NOC
$76B
| $3.27M | 0.08% |
9,371
-328
| -3% | -$110K |
|
149
Amazon
AMZN
$2.53T
| $3.21M | 0.08% |
44,320
-1,660
| -4% | -$119K |
|
|
MUI
150
DELISTED
BlackRock Municipal Income Fund, Inc.
MUI
| $3.19M | 0.08% |
243,495
-64,000
| -21% | -$861K |
|
Similar funds
OC
LGF
CCM
CL
WJWM
WA
GGHC
CCM
Welch & Forbes's Q1 2018 Portfolio in Review
As of Q1 2018, Welch & Forbes held 368 positions worth $3.88B, up 3.6% from $3.75B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Welch & Forbes deployed $219M of net new capital in Q1 2018, opening 30 new positions and adding to 108 existing holdings. Its largest new stake was AbbVie: 464,710 shares worth $44M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was CVS Health, an estimated $6.32M trimmed.
- Welch & Forbes's largest Q1 2018 buy was AbbVie: 464,710 shares worth $44M.
- Welch & Forbes added most to Johnson & Johnson in Q1 2018, an estimated $8.9M increase.
- Welch & Forbes's biggest Q1 2018 reduction was CVS Health, cutting an estimated $6.32M.
- Welch & Forbes fully exited Easterly Acquisition Corp in Q1 2018, selling an estimated $10M.
- Welch & Forbes's ten largest holdings make up 23% of its $3.88B portfolio in Q1 2018.
- Welch & Forbes opened 30 new positions and closed 12 in Q1 2018.
- Welch & Forbes's portfolio value rose 3.6% quarter-over-quarter to $3.88B.
Based on Welch & Forbes's 13F filing for Q1 2018, filed 12 Apr 2018.